Johnson & Johnson (JNJ -0.1%) finishes the day relatively flat, despite saying earlier that...

|About: Johnson & Johnson (JNJ)|By:, SA News Editor

Johnson & Johnson (JNJ -0.1%) finishes the day relatively flat, despite saying earlier that its Janssen Pharmaceuticals unit has been granted a positive opinion by the CHMP of the European Medicines Agency recommending approval of its prostate cancer treatment Zytiga.